Literature DB >> 24018791

Synthetic cannabinoids: a new frontier of designer drugs.

Erik W Gunderson.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24018791     DOI： 10.7326/0003-4819-159-8-201310150-00707

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice.

Authors:  Marcoita T Gilbert; Kathleen K Sulik; Eric W Fish; Lorinda K Baker; Deborah B Dehart; Scott E Parnell
Journal:  Neurotoxicol Teratol       Date:  2015-12-18       Impact factor: 3.763

2.  Synthetic Cannabinoids: Use and Predictors in a Community Sample of Young Adults.

Authors:  Celeste M Caviness; Golfo Tzilos; Bradley J Anderson; Michael D Stein
Journal:  Subst Abus       Date:  2014-09-15       Impact factor: 3.716

3.  Designer drugs 2015: assessment and management.

Authors:  Michael F Weaver; John A Hopper; Erik W Gunderson
Journal:  Addict Sci Clin Pract       Date:  2015-03-25

4.  Using cheminformatics to predict cross reactivity of "designer drugs" to their currently available immunoassays.

Authors:  Matthew D Krasowski; Sean Ekins
Journal:  J Cheminform       Date:  2014-05-10       Impact factor: 5.514

Review 5.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.